f
OCT 2016 BULLETIN American College of Surgeons
| 5
continued on next page
g
ab
Author bios*
*Titles and locations current at the time articles were submitted for publication.
DR. ALSEIDI (a) is a hepatobiliary and
pancreatic (HPB) and endocrine surgeon,
and director, HPB fellowship, Virginia
Mason Medical Center, Seattle, WA. He is a
member of the Young Fellows Association
( YFA) of the American College of Surgeons
(ACS) Governing Council (GC).
DR. ANNAMALAI (b) is a hepatobiliary
and transplant surgeon, Comprehensive
Transplant Center, Cedars Sinai
Medical Center, Los Angeles, CA.
DR. BAILEY (c) is Medical Director,
Advocacy, ACS Division of Advocacy
and Health Policy, Washington, DC.
h
d
DR. BROGHAMMER (d) is urologist
and assistant professor of urology,
department of urology, University of
Kansas Medical Center, Kansas City.
He is a member of the YFA ACS GC.
MR. CARMODY (e) is Government
Affairs Coordinator, ACS Division
of Advocacy and Health Policy.
DR. CHU (f) is professor of surgery,
department of surgery; vice-chair, academic
affairs; and chief, division of surgical
oncology, Louisiana State University Health
Sciences Center-Shreveport (LSUHSC-S).
DR. FANTUS (g) is vice-chairman,
department of surgery; medical director,
trauma services; and chief, section of surgical
critical care, Advocate Illinois Masonic
Medical Center. He is clinical professor of
surgery, University of Illinois College of
Medicine, Chicago, and Past-Chair, ad hoc
Trauma Registry Advisory Committee,
ACS Committee on Trauma (COT).
DR. GEORGE (h) is associate professor,
division of hematology and oncology,
University of Florida (UF), Gainesville;
director, GI (Gastrointestinal) Oncology
Program and Experimental Therapeutics
Incubator, UF Health Cancer Center; and
chair, NRG Oncology Colorectal Cancer
Committee, National Clinical Trials Network.
e
c
